Search by Drug Name or NDC
NDC 00074-1065-02 Skyrizi Details
Skyrizi
Skyrizi is a INTRAVENOUS KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is .
Product Information
| NDC | 00074-1065 |
|---|---|
| Product ID | 0074-1065_7718dd85-622c-478e-ae9b-91e14a1373c6 |
| Associated GPIs | |
| GCN Sequence Number | 084203 |
| GCN Sequence Number Description | risankizumab-rzaa WEAR INJCT 180 MG/1.2 SUBCUT |
| HIC3 | V4E |
| HIC3 Description | IL-23 RECEPTOR ANTAGONIST, MONOCLONAL ANTIBODY |
| GCN | 53397 |
| HICL Sequence Number | 045699 |
| HICL Sequence Number Description | RISANKIZUMAB-RZAA |
| Brand/Generic | Brand |
| Proprietary Name | Skyrizi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Risankizumab-rzaa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | INTRAVENOUS |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | AbbVie Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761105 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00074-1065-02 (00074106502)
| NDC Package Code | 0074-1065-02 |
|---|---|
| Billing NDC | 00074106502 |
| Package | 1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01) |
| Marketing Start Date | 2022-09-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |